ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $54,000 | +134.8% | 9,077 | +4.1% | 0.00% | – |
Q2 2019 | $23,000 | -11.5% | 8,721 | 0.0% | 0.00% | – |
Q1 2019 | $26,000 | +100.0% | 8,721 | 0.0% | 0.00% | – |
Q4 2018 | $13,000 | -59.4% | 8,721 | 0.0% | 0.00% | – |
Q3 2018 | $32,000 | +28.0% | 8,721 | 0.0% | 0.00% | – |
Q2 2018 | $25,000 | -21.9% | 8,721 | 0.0% | 0.00% | – |
Q1 2018 | $32,000 | +28.0% | 8,721 | 0.0% | 0.00% | – |
Q4 2017 | $25,000 | -34.2% | 8,721 | 0.0% | 0.00% | – |
Q3 2017 | $38,000 | -5.0% | 8,721 | 0.0% | 0.00% | – |
Q2 2017 | $40,000 | +8.1% | 8,721 | 0.0% | 0.00% | – |
Q1 2017 | $37,000 | +2.8% | 8,721 | 0.0% | 0.00% | – |
Q4 2016 | $36,000 | -74.3% | 8,721 | -50.0% | 0.00% | – |
Q3 2016 | $140,000 | +105.9% | 17,442 | +100.0% | 0.00% | – |
Q2 2016 | $68,000 | +1.5% | 8,721 | 0.0% | 0.00% | – |
Q1 2016 | $67,000 | -28.7% | 8,721 | 0.0% | 0.00% | – |
Q4 2015 | $94,000 | +56.7% | 8,721 | 0.0% | 0.00% | – |
Q3 2015 | $60,000 | -22.1% | 8,721 | 0.0% | 0.00% | – |
Q2 2015 | $77,000 | -10.5% | 8,721 | 0.0% | 0.00% | – |
Q1 2015 | $86,000 | -19.6% | 8,721 | 0.0% | 0.00% | – |
Q4 2014 | $107,000 | – | 8,721 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |